Preformulation studies of myricetin: A natural antioxidant flavonoid

Pharmazie

Volumn 69, Issue 1, 2014, Pages 19-26

  Yao, Yashu ^a   Lin, Guobei ^a   Xie, Yan ^a   Ma, Ping ^b   Li, Guowen ^a,c   Meng, Qianchao ^a   Wu, Tao ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Hospira Inc   (United States)

^c Shanghai TCM Integrated Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; ALCOHOL; BUFFER; CHLOROFORM; HEXANE; METHANOL; MYRICETIN; N,N DIMETHYLACETAMIDE; N,N DIMETHYLFORMAMIDE; ORGANIC SOLVENT; PETROLEUM ETHER; SOLUBILIZER; TETRAHYDROFURAN; TOLUENE; WATER;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG STABILITY; INTRINSIC DISSOLUTION RATE; LIPOPHILICITY; PARTITION COEFFICIENT; PH; PHYSICAL CHEMISTRY; PKA; TEMPERATURE;

ALGORITHMS; ANTIOXIDANTS; BUFFERS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLAVONOIDS; HYDROGEN-ION CONCENTRATION; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE;

EID: 84893142639     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.3076     Document Type: Article

References (15)

1. Sithisarn P, Michaelis M, Schubert-Zsilavecz M, Cinatl J.Jr (2013) Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells. Antiviral Res 97: 41-48.
2. Smith AJ, Kavuru P, Wojtas L, Zaworotko MJ, Shytle RD (2011) Cocrystals of quercetin with improved solubility and oral bioavailability. Mol Pharm 8: 1867-1876.
3. Sun M, GaoY, PeiY, Guo C, Li H, Cao F, Yu A, ZhaiG(2010) Development of nanosuspension formulation for oral delivery of quercetin. J Biomed Nanotechnol 6: 325-332.
4. Taubert D, Berkels R, Klaus W, Roesen R (2002) Nitric oxide formation and corresponding relaxation of porcine coronary arteries induced by plant phenols: essential structural features. J Cardiovasc Pharmacol 40: 701-713. (Pubitemid 36109288)
5. Tian XJ, Yang, XW, Yang X, Wang K (2009) Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. Int J Pharm 367: 58-64.
6. Wang M, Wang SJ, Hou W (2012) Study on preparation and dissolution of myricetin solid dispersions. Shi Yong Yao Wu Yu Lin Chuang 15: 281-283.
7. Wang NP, Qin JP, Zhong ZX, Chen XF, Li YJ (2008a) Contrast of the anti-thrombosis function between dripping pills and dispersible tablets of myricetin. Guangxi Zhong Yi Xue Yuan Xue Bao 11: 1-2.
8. Wang XY, Jiang ZT, Li R (2008b) Inclusion reaction of -cyclodextrin with its derivatives and natural antioxidant myricetin. Shi Pin Ke Xue 29: 125-128.
9. Wang Y, Cao J, Weng JH, Zeng S (2005) Simultaneous determination of quercetin, kaempferol and isorhamnetin accumulated human breast cancer cells, by high-performance liquid chromatography. J Pharm Biomed Anal 39: 328-333. (Pubitemid 41112156)
10. Weng CJ, YenGC(2012) Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev 31: 323-351.
11. XueCF, Guo JM, QianDW, Duan JA, ShuY(2011) Absorption of flavonoids from Abelmoschus manihot extract by in situ intestinal perfusion. Yao Xue Xue Bao 46: 454-459.
12. Yee S (1997) In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm Res 14: 763-766. (Pubitemid 27281671)
13. Zern TL, West KL, Fernandez ML (2003) Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J Nutr 133: 2268-2272. (Pubitemid 36841552)
14. Zhang JJ, Liu DP, Huang YT, Gao Y, Qian S (2012) Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm 436:311-317.
15. Zhang YH, Wang SJ, Xu K, Yang R, Wu SY, Liu Q (2010) Preparation and quality evaluation of myricetin microemulsion. ShenyangYaoKeDa Xue Xue Bao 27: 767-783.